Driving impairment and altered ocular activity under the effects of alprazolam and alcohol: A randomized, double-blind, placebo-controlled study

被引:2
|
作者
Aitken, Blair [1 ]
Hayley, Amie C. [1 ,2 ]
Ford, Talitha C. [1 ,3 ]
Geier, Lauren [4 ]
Shiferaw, Brook A. [1 ,2 ,5 ]
Downey, Luke A. [1 ,2 ,6 ]
机构
[1] Swinburne Univ Technol, Ctr Human Psychopharmacol, Hawthorn, Vic, Australia
[2] Austin Hlth, Inst Breathing & Sleep IBAS, Heidelberg, Vic, Australia
[3] Deakin Univ, Cognit Neurosci Unit, Geelong, Vic, Australia
[4] Forens Sci South Australia, Adelaide, Australia
[5] Seeing Machines, Canberra, ACT 2612, Australia
[6] Swinburne Univ Technol, Ctr Mental Hlth & Brain Sci, Hawthorn, Vic 3122, Australia
基金
英国医学研究理事会;
关键词
Alcohol; Alprazolam; Driving; Gaze entropy; Ocular monitoring; Road safety; PERFORMANCE; PREVALENCE; RISK; BENZODIAZEPINES; RESPONSIBILITY; PSYCHOMOTOR; DRUGS;
D O I
10.1016/j.drugalcdep.2023.110919
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Alprazolam, also known by trade-name Xanax, is regularly detected along with alcohol in blood samples of drivers injured or killed in traffic collisions. While their co-consumption is principally legal, policy guidelines concerning fitness-to-drive are lacking and methods to index impairment are underdeveloped. Methods: In this randomized, double-blind, placebo-controlled, crossover trial, we examined whether legally permissible levels of alcohol [target 0.04% blood alcohol concentration (BAC)], alprazolam (1 mg), and their combination impacts driving performance, and whether driving impairment can be indexed by ocular activity. Participants completed a test battery consisting of a 40-minute simulated highway drive with ocular parameters assessed simultaneously, the Karolinska Sleepiness Scale, and a confidence to drive assessment following four separate treatment combinations. The predictive efficacy of ocular parameters to identify alcohol and alprazolam-related driving impairment was also examined.Results: Among 21 healthy, fully licensed drivers (37% female, mean age 28.43, SD & PLUSMN; 3.96), driving performance was significantly impacted by alprazolam, alcohol, and their combination. Linear regression models revealed that the odds of an out-of-lane event occurring increased five-fold under the influence alprazolam alone and when combined with alcohol. An increase in gaze transition entropy (GTE) demonstrated the strongest association with the odds of an out-of-lane event occurring in the same minute, with both microsleeps and fixation rate achieving moderate accuracy across treatments.Conclusions: Alprazolam and alcohol, alone and in combination, impaired select aspects of vehicle control over time. GTE, microsleeps, and fixation rate show potential as real-time indicators of driving impairment and crash risk associated with alcohol and alprazolam consumption.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Effects of alcohol intoxication on driving performance, confidence in driving ability, and psychomotor function: a randomized, double-blind, placebo-controlled study
    Garrisson, Harriet
    Scholey, Andrew
    Verster, Joris C.
    Shiferaw, Brook
    Benson, Sarah
    PSYCHOPHARMACOLOGY, 2022, 239 (12) : 3893 - 3902
  • [2] Acute administration of alprazolam, alcohol and their combination on cognitive performance and mood: A randomised, double-blind, placebo-controlled study
    Aitken, Blair
    Hayley, Amie C.
    Ford, Talitha C.
    Geier, Lauren
    Shiferaw, Brook A.
    Downey, Luke A.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2023, 37 (12) : 1227 - 1237
  • [3] Effects of alcohol intoxication on driving performance, confidence in driving ability, and psychomotor function: a randomized, double-blind, placebo-controlled study
    Harriet Garrisson
    Andrew Scholey
    Joris C. Verster
    Brook Shiferaw
    Sarah Benson
    Psychopharmacology, 2022, 239 : 3893 - 3902
  • [4] A randomized, placebo-controlled, double-blind, pilot study of cannabis-related driving impairment assessed by driving simulator and self-report
    Meda, Shashwath A.
    Stevens, Michael C.
    Boer, Erwin R.
    Pittman, Brian
    Gueorguieva, Ralitza
    Huestis, Marilyn A.
    Pearlson, Godfrey D.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2025, : 364 - 372
  • [5] Effects of Alprazolam on Driving Ability, Memory Functioning and Psychomotor Performance: A Randomized, Placebo-controlled Study
    Joris C Verster
    Edmund R Volkerts
    Marinus N Verbaten
    Neuropsychopharmacology, 2002, 27 : 260 - 269
  • [6] Does a Medicinal Dose of Kava Impair Driving? A Randomized, Placebo-Controlled, Double-Blind Study
    Sarris, J.
    Laporte, E.
    Scholey, A.
    King, R.
    Pipingas, A.
    Schweitzer, I.
    Stough, C.
    TRAFFIC INJURY PREVENTION, 2013, 14 (01) : 13 - 17
  • [7] Effects of Alprazolam on driving ability memory functioning and psychomotor performance: A randomized, placebo-controlled study
    Verster, JC
    Volkerts, ER
    Verbaten, MN
    NEUROPSYCHOPHARMACOLOGY, 2002, 27 (02) : 260 - 269
  • [8] Driving performance and ocular activity following acute administration of 10 mg methylphenidate: A randomised, double-blind, placebo-controlled study
    Aitken, Blair
    Downey, Luke A.
    Rose, Serah
    Arkell, Thomas R.
    Shiferaw, Brook
    Hayley, Amie C.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2024, 38 (11) : 998 - 1006
  • [9] Acute methamphetamine and alcohol usage alters gaze behaviour during driving: A randomised, double-blind, placebo-controlled study
    Hayley, Amie C.
    Shiferaw, Brook
    Aitken, Blair
    Rositano, Joanna
    Downey, Luke A.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2024, 38 (07) : 636 - 646
  • [10] Effects of alcohol and energy drink on mood and subjective intoxication: a double-blind, placebo-controlled, crossover study
    Benson, Sarah
    Scholey, Andrew
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2014, 29 (04) : 360 - 369